水痘ワクチン市場レポート：2030年までの動向、予測、競合分析

水痘ワクチンの動向と予測

世界の水痘ワクチン市場は、2024年から2030年までのCAGRが5.8%で、2030年までに推定46億米ドルに達すると予測されます。この市場の主な促進要因は、世界中で予防接種プログラムが増加していること、水痘ワクチンの使用に対する一般市民の意識が高まっていること、予防接種プログラムにおける政府の貢献が増加していることです。世界の水痘ワクチン市場の将来は、病院や診療所市場でのビジネスチャンスにより有望視されています。

水痘ワクチン市場の洞察

Lucintelは、帯状疱疹が予測期間中に最も高い成長を遂げると予測しています。

同市場では、病院が予測期間中に高い成長を遂げると予想されます。

北米は、ワクチン接種プログラムが確立されており、人口増加に伴いワクチン接種率に対する需要が高まっているため、引き続き最大地域です。

市場規模・推計：水痘ワクチンの市場規模を金額（10億ドル）で推計。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

セグメント別分析：水痘ワクチンの製品タイプ別、用途別、最終用途別、地域別の市場規模を金額（10億ドル）で推計。

地域別分析：水痘ワクチン市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。

成長機会：水痘ワクチン市場の製品タイプ、用途、最終用途、地域別の成長機会分析。

戦略分析：水痘ワクチン市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の水痘ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界の水痘ワクチン市場動向（2018年～2023年）と予測（2024年～2030年）
• 製品タイプ別の世界の水痘ワクチン市場
  • 一価水痘ワクチン
  • 水痘混合ワクチン
• 用途別の世界の水痘ワクチン市場
  • おたふく風邪
  • 麻疹
  • 風疹
  • 水痘予防接種
  • 帯状疱疹
  • 免疫
• 最終用途別の世界の水痘ワクチン市場
  • 病院
  • クリニック
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の水痘ワクチン市場
• 北米の水痘ワクチン市場
• 欧州水痘ワクチン市場
• アジア太平洋の水痘ワクチン市場
• その他地域の水痘ワクチン市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品タイプ別の世界の水痘ワクチン市場の成長機会
  • 用途別の世界の水痘ワクチン市場の成長機会
  • 最終用途別の世界の水痘ワクチン市場の成長機会
  • 地域別の世界の水痘ワクチン市場の成長機会
• 世界の水痘ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の水痘ワクチン市場の生産能力拡大
  • 世界の水痘ワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Chickenpox Vaccine Trends and Forecast

The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines, and growing government contribution in immunization programs.

A more than 150-page report is developed to help in your business decisions.

Chickenpox Vaccine by Segment

The study includes a forecast for the global chickenpox vaccine by product type, application, end use, and region.

Chickenpox Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent Varicella Vaccine
• Combination Varicella Vaccine

Chickenpox Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Mumps
• Measles
• Rubella
• Varicella Immunization
• Herpes Zoster
• Immunization
• Chickenpox Vaccination

Chickenpox Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Others

Chickenpox Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Chickenpox Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Chickenpox Vaccine Market Insights

Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness higher growth over the forecast period.

North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Features of the Global Chickenpox Vaccine Market

Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the chickenpox vaccine market size?

Answer: The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for chickenpox vaccine market?

Answer: The global chickenpox vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the chickenpox vaccine market?

Answer: The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines and growing government contribution in immunization programs.

Q4. What are the major segments for chickenpox vaccine market?

Answer: The future of the chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key chickenpox vaccine market companies?

Answer: Some of the key chickenpox vaccine companies are as follows:

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Q6. Which chickenpox vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Q7. In chickenpox vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chickenpox Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Chickenpox Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Chickenpox Vaccine Market by Product Type
  • 3.3.1: Monovalent Varicella Vaccine
  • 3.3.2: Combination Varicella Vaccine
• 3.4: Global Chickenpox Vaccine Market by Application
  • 3.4.1: Mumps
  • 3.4.2: Measles
  • 3.4.3: Rubella
  • 3.4.4: Varicella Immunization
  • 3.4.5: Herpes Zoster
  • 3.4.6: Immunization
  • 3.4.7: Chickenpox Vaccination
• 3.5: Global Chickenpox Vaccine Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Chickenpox Vaccine Market by Region
• 4.2: North American Chickenpox Vaccine Market
  • 4.2.1: North American Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.2.2: North American Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
• 4.3: European Chickenpox Vaccine Market
  • 4.3.1: European Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.3.2: European Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
• 4.4: APAC Chickenpox Vaccine Market
  • 4.4.1: APAC Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.4.2: APAC Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
• 4.5: ROW Chickenpox Vaccine Market
  • 4.5.1: ROW Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.5.2: ROW Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
  • 6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
• 6.2: Emerging Trends in the Global Chickenpox Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Med
• 7.2: GlaxoSmithKline
• 7.3: Emcure Pharmaceuticals
• 7.4: Novo Medi Services
• 7.5: Sanofi
• 7.6: Takeda Pharmaceutical
• 7.7: Changchun BCHT Biotechnology
• 7.8: Green Cross Holdings
• 7.9: Merck
• 7.10: Mitsubishi Chemical Holdings